Portfolio mapping & regulatory signals

From product roster to portfolio concentration you can act on.

RegSig normalizes SKUs, ingredients, and claims; joins them to scored signals and origin context; and surfaces per-product exposure, urgency, and ownership—so leadership sees where risk concentrates and operators see the exact rows to work.

  • Portfolio risk concentration
  • Per-product exposure & ownership
  • Scored signals with origin context
IntakeExtractionSignal GenerationPortfolio IntelligenceUnified pipeline from source intake to decision-ready portfolio output

Product offerings

Signals Explorer

Traceable signal records with jurisdiction tags, source routing, and evidence-linked details.

Explore signals

Institutional access

Enterprise programs with invite-only admin portal, white-label deployment, developer support, and GRC API integration.

Request institutional access

Platform flow

How product, signals, and portfolio fit together

Intake & normalization

Signals & provenance

Portfolio mapping

Dashboards & review

Surfaces

Three surfaces, one mapping

Executives orient on concentration and urgency; operators validate evidence and owners; portfolio teams sequence work. Each view reads from the same normalized join between products and signals.

Dashboard

Signals

Portfolio assessment

Governance & access

Trajectory-aware signals stay tied to evidence and portfolio impact—built for operator review, not opaque alerts.

Start with individual usage-based access when you are ready. Enterprise teams use institutional onboarding with fit and governance review.

  • Human-in-the-loop review stays in operator workflows.
  • Recommendations remain evidence-linked and auditable.
  • Portfolio mapping is role-aware with explicit ownership.